The Pediatric Palliative Care Drugs Market, estimated at USD 91.79 Bn in 2025, is expected to exhibit a CAGR of 5.1% and reach USD 130.02 Bn by 2032.
The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are improving treatment outcomes and operational efficiency. Supportive regulations, rising R&D investments, and a strong focus on patient-centric care are creating new opportunities for pharmaceutical companies.
The strategies adopted by key market players like acquisitions is expected to drive the global pediatric palliative care drugs market growth over the forecast period. For instance, on September 13, 2022, Eton Pharmaceuticals, Inc., a U.S. based pharmaceutical company, announced the acquisition of the product betaine anhydrous for oral solution. This acquisition allowed Eton Pharmaceuticals, Inc. to further advance its mission of commercializing products for small, underserved orphan populations, and it will continue to seek out attractive late-stage rare disease such as Stoneman Syndrome, Alkaptonuria products to expand its portfolio.
Global Pediatric Palliative Care Drugs Market - Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China), in the last months of 2019, as "coronavirus disease 2019" or COVID-19. This virus spreads quickly, and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries, such as India, China, Brazil, and others, faced problems regarding the transportation of drugs from one place to another.
COVID-19 had a negative impact on the global pediatric palliative care drugs market due to restrictions such as lockdowns imposed worldwide. For instance, according to an article published by Journal of Pain and Symptom Management in July 2022, the impact of COVID-19 pandemic and lockdowns was studied in the U.K. 106 children and young people were studied having life-limiting or life-threatening conditions. As per the study, disruption within treatment, reduction in support and coordination from the services providers resulted in delay of treatment. This impacted negatively on treatment and hence on global pediatric palliative care drugs market.
Global Pediatric Palliative Care Drugs Market: Key Developments
Increasing launch of newer services that can improve palliative care are expected to drive the market growth.
For instance, on October 7, 2021, 11 palliative care organizations such as CanSupport, Delhi; Romila Palliative care, Mumbai; Tata Memorial Hospital, Mumbai; PalCare, Mumbai; Sukoon Nilaya, Mumbai; Cipla Palliative Care & Training Centre and others launched ‘Saath Saath’ helpline in India for people and their families who need palliative care. The helpline is a national free-of-cost service where patients, caregivers and healthcare providers can be connected to the nearest palliative care center when required. By offering pan-India coverage in multiple languages, this service aims that no person with a serious illness feels alone and can be connected to options such as pain relief, physiotherapy, diet advice, and family counselling to assist them and their caregiver, with the help of qualified healthcare professionals and trained volunteers.